5XJ3: Complex structure of ipilimumab-scFv and CTLA-4
Complex structure of ipilimumab-scFv and CTLA-4. Determined by X-ray diffraction at 3.2 Å resolution. Released 25 Apr 2018.
- Method
- X-ray diffraction
- Resolution
- 3.2 Å
- Organism
- Homo sapiens
- Chains
- 12
- Atoms
- 10,424
- Mol. weight
- 154.67 kDa
- Released
- 25 Apr 2018
Explore 5XJ3 in 3D
Show helices and sheets
RCSB PDB
PDBe
Secondary structure: helices and β-sheets
5XJ3 contains 36 α-helices and 134 β-strands across 12 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.
Chain A: 3 helices, 12 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 3-7 | 5 | 1 |
| β-strand | 11-12 | 2 | 2 |
| β-strand | 18-25 | 8 | 1 |
| α-helix | 29-31 | 3 | |
| β-strand | 34-39 | 6 | 3 |
| β-strand | 45-51 | 7 | 3 |
| β-strand | 58-60 | 3 | 3 |
| β-strand | 68-73 | 6 | 1 |
| β-strand | 78-83 | 6 | 1 |
| α-helix | 88-90 | 3 | |
| β-strand | 92-99 | 8 | 3 |
| α-helix | 100 | 1 | |
| β-strand | 105-108 | 4 | 3 |
| β-strand | 112-114 | 3 | 3 |
| β-strand | 115-116 | 2 | 2 |
Chains B and K: 3 helices, 12 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 4-7 | 4 | 4 |
| β-strand | 10-13 | 4 | 5 |
| β-strand | 19-25 | 7 | 4 |
| β-strand | 34-39 | 6 | 5 |
| β-strand | 45-50 | 6 | 5 |
| β-strand | 54-55 | 2 | 5 |
| α-helix | 56 | 1 | |
| β-strand | 63-67 | 5 | 4 |
| β-strand | 71-76 | 6 | 4 |
| α-helix | 81-83 | 3 | |
| β-strand | 85-91 | 7 | 5 |
| β-strand | 94 | 1 | 6 |
| α-helix | 97 | 1 | |
| β-strand | 98-99 | 2 | 5 |
| β-strand | 103-107 | 5 | 5 |
Chains C and F: 3 helices, 10 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 40-41 | 2 | 7 |
| β-strand | 45-47 | 3 | 6 |
| β-strand | 54-60 | 7 | 7 |
| β-strand | 69-77 | 9 | 6 |
| β-strand | 80-87 | 8 | 6 |
| α-helix | 94-95 | 2 | |
| β-strand | 103-108 | 6 | 7 |
| β-strand | 111-116 | 6 | 7 |
| α-helix | 121-123 | 3 | |
| β-strand | 125-133 | 9 | 6 |
| α-helix | 139 | 1 | |
| β-strand | 140-143 | 4 | 6 |
| β-strand | 147-150 | 4 | 6 |
Chain D: 2 helices, 11 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 3-7 | 5 | 8 |
| β-strand | 10-12 | 3 | 9 |
| β-strand | 18-25 | 8 | 8 |
| α-helix | 29-31 | 3 | |
| β-strand | 34-39 | 6 | 9 |
| β-strand | 45-51 | 7 | 9 |
| β-strand | 58-60 | 3 | 9 |
| β-strand | 68-73 | 6 | 8 |
| β-strand | 78-83 | 6 | 8 |
| β-strand | 92-99 | 8 | 9 |
| α-helix | 100 | 1 | |
| β-strand | 105-108 | 4 | 9 |
| β-strand | 112-116 | 5 | 9 |
Chain E: 3 helices, 12 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 4-7 | 4 | 10 |
| β-strand | 10-13 | 4 | 11 |
| β-strand | 19-25 | 7 | 10 |
| β-strand | 34-39 | 6 | 11 |
| β-strand | 46-50 | 5 | 11 |
| β-strand | 54-55 | 2 | 11 |
| α-helix | 56 | 1 | |
| β-strand | 63-67 | 5 | 10 |
| β-strand | 71-76 | 6 | 10 |
| α-helix | 81-83 | 3 | |
| β-strand | 85-91 | 7 | 11 |
| β-strand | 94 | 1 | 12 |
| α-helix | 97 | 1 | |
| β-strand | 98-99 | 2 | 11 |
| β-strand | 103-107 | 5 | 11 |
Chain G: 2 helices, 11 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 3-7 | 5 | 14 |
| β-strand | 10-12 | 3 | 15 |
| β-strand | 18-25 | 8 | 14 |
| α-helix | 29-31 | 3 | |
| β-strand | 34-39 | 6 | 15 |
| β-strand | 45-51 | 7 | 15 |
| β-strand | 58-60 | 3 | 15 |
| β-strand | 68-73 | 6 | 14 |
| β-strand | 78-83 | 6 | 14 |
| β-strand | 92-98 | 7 | 15 |
| α-helix | 99-100 | 2 | |
| β-strand | 107-108 | 2 | 15 |
| β-strand | 112-116 | 5 | 15 |
Chain H: 4 helices, 12 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 4-7 | 4 | 16 |
| β-strand | 10-13 | 4 | 17 |
| β-strand | 19-25 | 7 | 16 |
| β-strand | 34-39 | 6 | 17 |
| β-strand | 45-49 | 5 | 17 |
| α-helix | 54 | 1 | |
| β-strand | 55 | 1 | 17 |
| α-helix | 56 | 1 | |
| β-strand | 63-67 | 5 | 16 |
| β-strand | 71-76 | 6 | 16 |
| α-helix | 81-83 | 3 | |
| β-strand | 85-91 | 7 | 17 |
| β-strand | 94 | 1 | 18 |
| α-helix | 97 | 1 | |
| β-strand | 98-99 | 2 | 17 |
| β-strand | 103-107 | 5 | 17 |
Chain I: 4 helices, 10 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 40-41 | 2 | 19 |
| β-strand | 45-47 | 3 | 18 |
| α-helix | 48-49 | 2 | |
| β-strand | 54-60 | 7 | 19 |
| β-strand | 69-75 | 7 | 18 |
| β-strand | 82-89 | 8 | 18 |
| α-helix | 94-95 | 2 | |
| β-strand | 103-108 | 6 | 19 |
| β-strand | 111-116 | 6 | 19 |
| α-helix | 121-123 | 3 | |
| β-strand | 125-133 | 9 | 18 |
| α-helix | 139 | 1 | |
| β-strand | 140-142 | 3 | 18 |
| β-strand | 147-150 | 4 | 18 |
2 more chain groups are not listed. Open the entry in the viewer and use the sequence panel to see them.
Molecules and chains
| Molecule | Chains | Type | Length | Organism | UniProt |
|---|
| ipilimumab-VH | A, D, G, J | protein | 118 | Homo sapiens | |
| ipilimumab-VL | B, E, H, K | protein | 109 | Homo sapiens | |
| Cytotoxic T-lymphocyte protein 4 | C, F, I, L | protein | 127 | Homo sapiens | P16410 (AlphaFold model) |
Sequence of entity 1 (A, D, G, J), FASTA
>5XJ3_1 ipilimumab-VH (chains A, D, G, J)
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYY
ADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSS
Sequence of entity 2 (B, E, H, K), FASTA
>5XJ3_2 ipilimumab-VL (chains B, E, H, K)
EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGAFSRATGIP
DRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIKR
Sequence of entity 3 (C, F, I, L), FASTA
>5XJ3_3 Cytotoxic T-lymphocyte protein 4 (chains C, F, I, L)
MKAMHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNE
LTFLDDSICTGTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDP
EPCPDSD
Primary citation
Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies. He, M., Chai, Y., Qi, J. et al. Oncotarget (2017) 8:67129-67139. DOI 10.18632/oncotarget.18004 · PubMed
Other PDB entries of the same protein (UniProt P16410 (AlphaFold model), which also has an AlphaFold model), best resolution first:
- 7CIO 1.1 Å, Molecular interactions of cytoplasmic region of CTLA-4 with SH2 domains of PI3-kinase
- 9DQ3 1.64 Å, Crystal structure of engineered Ipilimumab (mipi.4) Fab in complex with human CTLA-4
- 3OSK 1.8 Å, Crystal structure of human CTLA-4 apo homodimer
- 5GGV 2.0 Å, CTLA-4 in complex with tremelimumab Fab
- 3BX7 2.1 Å, Engineered Human Lipocalin 2 (LCN2) in Complex with the Extracellular Domain of Human…
- 7ELX 2.14 Å, The crystal structure of CTLA-4 and Fab
- 7DV4 2.38 Å, Crystal structure of anti-CTLA-4 VH domain in complex with human CTLA-4
- 7SU0 2.41 Å, Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.105 in complex with…
- 7SU1 2.53 Å, Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with…
- 2X44 2.6 Å, Structure of a strand-swapped dimeric form of CTLA-4
- 6RP8 2.6 Å, Crystal Structure of Ipilimumab Fab complexed with CTLA-4 at 2.6A resolution
- 8GAB 2.72 Å, Crystal structure of CTLA-4 in complex with a high affinity CTLA-4 binder
Browse structure collections
About this viewer
MolViewer shows 5XJ3 directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.